SOURCE: PharmStar Pharmaceuticals, Inc.

April 28, 2011 14:56 ET

PharmStar Pharmaceuticals, Inc. Publishes Quarterly Financial Report

ROCKY MOUNT, NC--(Marketwire - Apr 28, 2011) - PharmStar Pharmaceuticals, Inc., (PINKSHEETS: PHAR) (the "Company"), a U.S. drug developer, manufacturer and marketer of the FDA-approved, Over-the-Counter (OTC) liquid pain reliever Aquaprin™, today announced that it has published its financial report for the quarter ended March 31, 2011 on the OTC Markets website. The report may be found here:

The Company's financial statements, which were filed in advance of the OTC Markets Group's deadline of May 15, 2011, include the recent acquisition of the Company's pharmaceutical subsidiary effective as of February 28, 2011. The Company's financials now reflect the valuation of the intellectual property related to its primary product, the liquid pain reliever Aquaprin™.

About PharmStarPharmaceuticals
PharmStar Pharmaceuticals, Inc. is a U.S.-based drug development, manufacturing and marketing company and the innovator of Aquaprin™, an FDA-approved Over-the-Counter (OTC) liquid pain reliever. In development since 1993 with over $3 million invested to-date, Aquaprin™ is a liquid derivative of aspirin based on a patent-pending formula. The product is designed to dissolve nearly instantly in just 1.5 ounces of water, which can be absorbed into the bloodstream up to 10 times faster than traditional OTC pain relievers, and with little to no stomach upset. PharmStar's headquarters are located in Rocky Mount, NC. For more information, visit

Forward-Looking Statements Disclosure
This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "will," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.

Contact Information